ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional

Clinical Trial Description

Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups, providing a more scientific clinical dose selection basis for the anesthesia induction application of Remazolam. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT03638713` - Comparison of Procedural Sequences in Same-day Painless Bidirectional Endoscopy With Colonoscopic Water Exchange Method	N/A
Not yet recruiting	`NCT04973878` - The Optimal Sequence in Same-day Bidirectional Endoscopy Under Deep Anesthesia.	N/A
Unknown status	`NCT01491126` - Single Center Open Prospective Study for the Comparison of Procedural Sequence in Same Day Consecutive Bidirectional Endoscopy	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03638713 - Comparison of Procedural Sequences in Same-day Painless Bidirectional Endoscopy With Colonoscopic Water Exchange Method

N/A

Not yet recruiting

NCT04973878 - The Optimal Sequence in Same-day Bidirectional Endoscopy Under Deep Anesthesia.

N/A

Unknown status

NCT01491126 - Single Center Open Prospective Study for the Comparison of Procedural Sequence in Same Day Consecutive Bidirectional Endoscopy

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06121609
Study type	Interventional
Source	Tongji Hospital
Contact	mujun Chang, Dr.
Phone	+862783663625
Email	changmujun@hotmail.com
Status	Recruiting
Phase	Phase 4
Start date	January 15, 2024
Completion date	December 31, 2024

ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children — ED90

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms